Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProQuad Dose Selection Study
NCT00986232Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Apr 1999
- Primary completion
- Apr 2000
- Modality
- Live Attenuated Vaccines
01
Overview
A Phase 2 trial of varicella virus vaccine live in measles, mumps, rubella, varicella (VZV), sponsored by Merck & Co.. Started Apr 1999; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00986232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986232.